Rituximab Induced Cytokine Release Syndrome in an Ms Patient: A Case Report

Rituximab Induced Cytokine Release Syndrome in an Ms Patient: A Case Report Publisher

Etemadifar M¹ ; Salari M² ; Saeri M³ ; Sigari AA³ ; Ebrahimi Pelarti S³

Show Affiliations

1. Department of Neurosurgery, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
2. Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3. Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Clinical Case Reports Published:2021

Abstract

Cytokine release syndrome with rituximab has been reported in certain diseases, however, it is rarely reported in MS patients treated with rituximab. The treating physician should suspect the syndrome when typical signs and symptoms appear. © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

2. Anti-Cd20 Therapies for Pediatric-Onset Multiple Sclerosis: A Systematic Review, Multiple Sclerosis and Related Disorders (2024)

3. Efficacy and Safety of Rituximab in Neuromyelitis Optica: Review of Evidence, Journal of Research in Medical Sciences (2017)

4. Efficacy and Safety of Rituximab in Multiple Sclerosis: A Systematic Review and Meta-Analysis, Acta Neurologica Belgica (2023)

5. Immunotherapy a New Hope for Cancer Treatment: A Review, Pakistan Journal of Biological Sciences (2018)

6. The Prevalence of Cancer in Patients With Multiple Sclerosis (Ms) Who Received Rituximab: A Systematic Review and Meta-Analysis; [La Prevalencia De Cancer En Pacientes Con Esclerosis Multiple (Em) Que Recibieron Rituximab: Una Revision Sistematica Y Meta-Analisis], Neurologia (2025)

Experts (# of related papers)

Masoud Etemadifar (2)

Farzin Khorvash (1)

Style	Citing Format
MLA	Etemadifar M, et al.. "Rituximab Induced Cytokine Release Syndrome in an Ms Patient: A Case Report." Clinical Case Reports, vol. 9, no. 7, 2021, pp. -.
APA	Etemadifar M, Salari M, Saeri M, Sigari AA, Ebrahimi Pelarti S (2021). Rituximab Induced Cytokine Release Syndrome in an Ms Patient: A Case Report. Clinical Case Reports, 9(7), -.
Chicago	Etemadifar M, Salari M, Saeri M, Sigari AA, Ebrahimi Pelarti S. "Rituximab Induced Cytokine Release Syndrome in an Ms Patient: A Case Report." Clinical Case Reports 9, no. 7 (2021): -.
Harvard	Etemadifar M et al. (2021) 'Rituximab Induced Cytokine Release Syndrome in an Ms Patient: A Case Report', Clinical Case Reports, 9(7), pp. -.
Vancouver	Etemadifar M, Salari M, Saeri M, Sigari AA, Ebrahimi Pelarti S. Rituximab Induced Cytokine Release Syndrome in an Ms Patient: A Case Report. Clinical Case Reports. 2021;9(7):-.
BibTex	@article{ author = {Etemadifar M and Salari M and Saeri M and Sigari AA and Ebrahimi Pelarti S}, title = {Rituximab Induced Cytokine Release Syndrome in an Ms Patient: A Case Report}, journal = {Clinical Case Reports}, volume = {9}, number = {7}, pages = {-}, year = {2021} }
RIS	TY - JOUR AU - Etemadifar M AU - Salari M AU - Saeri M AU - Sigari AA AU - Ebrahimi Pelarti S TI - Rituximab Induced Cytokine Release Syndrome in an Ms Patient: A Case Report JO - Clinical Case Reports VL - 9 IS - 7 SP - EP - PY - 2021 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract